SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7675673
Source:
http://linkedlifedata.com/resource/pubmed/id/7675673
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0131965
,
umls-concept:C0332281
,
umls-concept:C0348013
,
umls-concept:C0377401
,
umls-concept:C0441723
,
umls-concept:C1273870
pubmed:issue
4
pubmed:dateCreated
1995-10-19
pubmed:abstractText
PURPOSES/OBJECTIVES: To determine the effect of duration of infusion time on venous irritation in patients receiving vinorelbine tartrate (Navelbine, Burroughs Wellcome Co., Research Triangle Park, NC) in combination with cisplatin or mitomycin.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7675673-8577616
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7809033
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycins
,
http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine
,
http://linkedlifedata.com/resource/pubmed/chemical/vinorelbine
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0190-535X
pubmed:author
pubmed-author:GrallaR JRJ
,
pubmed-author:RehmeyerT ATA
,
pubmed-author:RittenbergC NCN
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
707-10
pubmed:dateRevised
2011-1-11
pubmed:meshHeading
pubmed-meshheading:7675673-Adult
,
pubmed-meshheading:7675673-Aged
,
pubmed-meshheading:7675673-Aged, 80 and over
,
pubmed-meshheading:7675673-Antineoplastic Agents
,
pubmed-meshheading:7675673-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:7675673-Cisplatin
,
pubmed-meshheading:7675673-Colorectal Neoplasms
,
pubmed-meshheading:7675673-Female
,
pubmed-meshheading:7675673-Humans
,
pubmed-meshheading:7675673-Infusions, Intravenous
,
pubmed-meshheading:7675673-Lung Neoplasms
,
pubmed-meshheading:7675673-Male
,
pubmed-meshheading:7675673-Middle Aged
,
pubmed-meshheading:7675673-Mitomycins
,
pubmed-meshheading:7675673-Oncologic Nursing
,
pubmed-meshheading:7675673-Phlebitis
,
pubmed-meshheading:7675673-Prospective Studies
,
pubmed-meshheading:7675673-Time Factors
,
pubmed-meshheading:7675673-Vascular Diseases
,
pubmed-meshheading:7675673-Vinblastine
pubmed:year
1995
pubmed:articleTitle
Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine)
pubmed:affiliation
Ochsner Cancer Institute, New Orleans, LA, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study